The role and efficacy of multidisciplinary council in the bone and soft tissue tumor patients

Year 2021, , 278 - 283, 04.05.2021

Sina Coşkun , Nevzat Dabak , Hasan Göçer , Ferhat Say

https://doi.org/10.18621/eurj.716555

Abstract

Objectives: Bone and soft tissue tumors have become more common and recognized diseases with developing medical technologies. The life span of the patients has been prolonged with more effective treatment methods and developing technology. Regardless of their area of expertise, the concept of multidisciplinary tumor approach has emerged in recent years, since it is difficult for a single physician to manage a malignant mass treatment process. For this purpose, we aimed to share our multidisciplinary bone and soft tissue tumor council data results.

Methods: Patients who were evaluated at the Department of Orthopedics and Traumatology of Ondokuz Mayis University between January 2004 and June 2017 were evaluated retrospectively. For this study, the weekly archived tumor council forms were evaluated and the data were transferred to the computer via Microsoft Excel and SPSS programs. The database for the specified years was created and the results were evaluated and the database was evaluated.

Results: A total of 2788 patients were included in the study. After the patients with data deficiency were removed, 2397 patients were the subject of the study. In the evaluation of the first 1960 patients, 658 primary bone tumors, 577 primary soft tissue tumors, 356 cases of metastases and 374 non-tumoral cases were detected. The most common benign bone tumor was enchondroma, while the most common malignant bone tumor was osteosarcoma. The most common benign soft tissue tumor was lipoma, whereas the most common malignant soft tissue tumor was malignant mesenchymal tumor. The most common non-tumor cause was chronic infection. The diagnosis of 203 patients was different from the definitive diagnosis.

Conclusions: In this study, we determined the epidemiological distribution of the cases evaluated in the multidisciplinary tumor council in the Middle Black Sea and the role of multidisciplinaryapproach in treatment and survival has a positive effect especially in selected patient groups.

Keywords

Multidisciplinary approach, benign bone tumor, soft tissue tumor, sarcomas

References

• 1. Yuceturk G, Sabah D, Kececi B, Kara AD, Yalcinkaya S. Prevalence of bone and soft tissue tumors. Acta Orthop Traumatol Turc 2011;45:135-43.
• 2. Hung Y, Ko W, Liu W, Chow C, Kwok Y, Wong C, et al. Local review of treatment of hand enchondroma (artificial bone substitute versus autologous bone graft) in a tertiary referral centre: 13 years’ experience. Hong Kong Med J 2015;21:217-23.
• 3. Jewusiak EM, Spence KF, Sell KW. Solitary benign enchondroma of the long bones of the hand: Results of curettage and packing with freeze-dried cancellous-bone allograft. JBJS 1971;53:1587-90.
• 4. Picci P, Manfrini M, Fabbri N, Gambarotti M, Vanel D. Atlas of musculoskeletal tumors and tumorlike lesions: the Rizzoli case archive: Springer Science & Business Media; 2014.
• 5. Hochman MG, Wu JS. MR imaging of common soft tissue masses in the foot and ankle. Magn Reson Imaging Clin N Am 2017;25:159-81.
• 6. Bechsgaard T, Lelkaitis G, Jensen KE, Ewertsen C. Diagnosis of bone metastasis from thyroid carcinoma: a multidisciplinary approach. Acta Radiol Open 2015;4:2058460115603248.
• 7. Satoh T, Ishiyama H. [Current diagnosis and the multidisciplinary approach to the treatment of bone metastases in patients with prostate cancer]. Nihon Rinsho. 2016;74(1):129-36. [Aeticle in Japanese]
• 8. Gaspar N, Hawkins DS, Dirksen U, Lewis IJ, Ferrari S, Le Deley M-C, et al. Ewing sarcoma: current management and future approaches through collaboration. J Clin Oncol 2015;33:3036-46.
• 9. Wittig JC, Bickels J, Priebat D, Jelinek J, Kellar-Graney K, Shmookler B, et al. Osteosarcoma: a multidisciplinary approach to diagnosis and treatment. Am Fam Physician 2002;65:1123-32.
• 10. Yokoyama R, Beppu Y, Tobisu K-i, Moriya Y, Uchiyama K, Kito M, et al. A multidisciplinary approach to the treatment of malignant pelvic bone tumors: results with eight consecutive patients. J Orthop Sci 2000;5:449-56.
• 11. Siegel GW, Biermann JS, Chugh R, Jacobson JA, Lucas D, Feng M, et al. The multidisciplinary management of bone and soft tissue sarcoma: an essential organizational framework. J Multidiscip Healthc 2015;8:109-15.
• 12. Papagelopoulos PJ, Mavrogenis AF, Mastorakos DP, Patapis P, Soucacos PN. Current concepts for management of soft tissue sarcomas of the extremities. J Surg Orthop Adv 2008;17:204-15.
• 13. Siebenrock KA, Hertel R, Ganz R. Unexpected resection of soft-tissue sarcoma. More mutilating surgery, higher local recurrence rates, and obscure prognosis as consequences of improper surgery. Arch Orthop Trauma Surg 2000;120:65-9.
• 14. Umer HM, Umer M, Qadir I, Abbasi N, Masood N. Impact of unplanned excision on prognosis of patients with extremity soft tissue sarcoma. Sarcoma 2013;2013:498604.
• 15. Alamanda VK, Delisca GO, Mathis SL, Archer KR, Ehrenfeld JM, Miller MW, et al. The financial burden of reexcising incompletely excised soft tissue sarcomas: a cost analysis. Ann Surg Oncol 2013;20:2808-14.
• 16. Venkatesan M, Richards C, McCulloch T, Perks A, Raurell A, Ashford R, et al. Inadvertent surgical resection of soft tissue sarcomas. Eur J Surg Oncol 2012;38:346-51.
• 17. Coventry MB. The differential diagnosis of malignant bone tumors. Ann Surg 1950;132:888-98.